Tweet
CTV News
<img alt="" height="1" width="1" />
Pfizer's experimental breast cancer drug meets study's survival goal
CTV News
Drugmaker Pfizer Inc. said Monday that a midstage study of its experimental drug for advanced breast cancer, palbociclib, met the main goal. The world's second-biggest drugmaker said the drug, combined with another medicine called letrozole, increased ...
Pfizer bucks declines on cancer drug trial hopesFinancial Times
Palbociclib + Letrozole Improve Survival in Breast CancerMonthly Prescribing Reference
Pfizer breast cancer drug hits midstage study goalMiamiHerald.com
all 55 news articles »
More...